These findings demonstrate the feasibility of assessing LUAD histological subtypes at the single-cell level and highlight the role of PD-L1-expressing tumor endothelial cells in suppressing immune-responsive CD8+ T cells in stage IA LUAD [50]. This evidence concerns the gene CD8A and neoplasm.